ARCHIVES

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975

DCCR Free Up $5 Million; New Policy Limits Core Support

November 5, 1976

CDC Awaits Results Of Viral Cultures Of Bahama’s Serum For AIDs Contamination Before Taking Action

July 19, 1985

NCI Awards $6.7 Million For Breast Cancer Research.

September 8, 2000

Breast Cancer Overview Correlates Incidence Increase With Other Factors

July 29, 1988

ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position

December 19, 2014